Adult neurogenesis in the hippocampus and the subventricular zone is regulated by a complex interplay of cellular mechanisms that control stem cell quiescence, proliferation, differentiation, survival, and integration. These mechanisms operate at molecular, cellular, immune, metabolic, and systemic levels, and their balance determines the rate at which new neurons are produced and incorporated into existing circuits. Understanding these regulators clarifies why neurogenesis varies with age, experience, and disease, and why interventions such as exercise or inflammation have powerful effects on brain plasticity.
Niche signals and molecular pathways
The neural stem cell niche supplies local signals that bias stem cells toward staying dormant or entering the cell cycle. Classic developmental pathways including Notch signaling, Wnt signaling, Bone Morphogenetic Protein and Sonic Hedgehog remain active in adult niches and steer fate decisions. Fiona Doetsch at the University of Basel described how Notch activity helps maintain quiescence among subventricular zone stem cells, preserving the stem cell pool. Growth factors such as BDNF, FGF-2, and VEGF delivered by niche cells and vasculature promote proliferation and survival; Fred H. Gage at the Salk Institute linked physical activity and environmental enrichment to enhanced hippocampal neurogenesis in part through BDNF-dependent pathways. Neurotransmitters also act as niche cues: GABAergic signaling can keep progenitors immature while glutamatergic inputs promote maturation, illustrating that synaptic activity couples circuit function to neuron production.
Intrinsic and epigenetic control
Cell-autonomous programs determine a progenitor’s competence to divide and differentiate. Transcription factors such as Sox2, NeuroD, and others define lineage progression, while core cell-cycle regulators control proliferation. Arturo Alvarez-Buylla at the University of California San Francisco studied transcriptional networks that establish neural stem cell identity and timing of differentiation. Layered on top of transcriptional programs are epigenetic mechanisms: DNA methylation, histone modifications, and microRNAs reshape chromatin to permit or restrict neuronal gene expression. Hongjun Song and Guo-li Ming at the University of Pennsylvania have described how these epigenetic regulations influence both the pace and fidelity of neuronal differentiation, making outcomes highly context-dependent and sensitive to prior activity or stress.
Immune, metabolic and environmental influences
Microglia and systemic factors provide additional regulatory axes. Microglia perform synaptic pruning and phagocytosis of newborn cells and release cytokines that can either support or suppress neurogenesis; Josefina Sierra at the Instituto Cajal CSIC has characterized microglial roles in modulating hippocampal neuron survival. Circulating molecules from blood alter niche behavior: Tony Wyss-Coray at Stanford reported that blood-borne factors associated with youth can enhance neural plasticity, while aging-related factors suppress it. Cellular metabolism and mitochondrial health regulate progenitor competence, linking energy status to division rates. Environmental and cultural factors—levels of physical activity, chronic stress, diet, and exposure to pollutants—translate into molecular signals that shift these regulatory networks. Gerd Kempermann at the German Center for Neurodegenerative Diseases showed how lifestyle and genetics together shape baseline neurogenic capacity across populations.
Together, these mechanisms explain why adult neurogenesis declines with age, is boosted by enriched activity, and is disrupted by chronic inflammation or metabolic disease. Because new neurons contribute to memory formation, mood regulation, and recovery after injury, modulating these cellular regulators holds promise for therapies, but interventions must target multiple axes to be effective and safe. Nuanced understanding of niche heterogeneity across brain regions and individuals remains essential for translating basic mechanisms into clinical benefit.